2023

1. Jinghui Liu, Yue Zhao, Daheng He,Katelyn M. Jones,Shan Tang, Derek B. Allison,Yanquan Zhang,Jing Chen,Qiongsi Zhang, Xinyi Wang, Chaohao Li, Chi Wang, Lang Li, and Xiaoqi Liu,A kinome-wide CRISPR screen identifies CK1α as a target to overcome enzalutamide resistance of prostate cancer, Cell Reports Medicine 4, 101015, April 18, 2023 https://doi.org/10.1016/j.xcrm.2023.101015
2. Chaohao Li,Derek B. Allison,Daheng He,Fengyi Mao,Xinyi Wang,Piotr Rychahou,Ibrahim A. Imam,Yifan Kong,Qiongsi Zhang,Yanquan Zhang,Jinghui Liu,Ruixin Wang,Xiongjian Rao,Sai Wu,B. Mark Evers,Qing Shao,Chi Wang,Zhiguo Li,Xiaoqi Liu  Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling,  PLoS Genetics, 2023 https://doi.org/10.1371/journal.pgen.1011017
3. Yifan Kong ,Chaohao Li ,Jinpeng Liu ,Sai Wu ,Min Zhang,Derek B. Allison,Faisal Hassan,Daheng He,Xinyi Wang,Fengyi Mao,Qiongsi Zhang,Yanquan Zhang,Zhiguo Li,Chi Wang,Xiaoqi Liu Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD,  PLoS Genetics, Published: June 17, 2024 https://doi.org/10.1371/journal.pgen.1011309

2022

1. Kong, Y., D. B. Allison, Q. Zhang, D. He, Y. Li, F. Mao, C. Li, Z. Li, Y. Zhang, J. Wang, C. Wang, C. F. Brainson, and X. Liu. "The Kinase Plk1 Promotes the Development of Kras/Tp53-Mutant Lung Adenocarcinoma through Transcriptional Activation of the Receptor Ret." Sci Signal 15, no. 754 (Oct 4 2022): eabj4009.
2. Li, C., J. Liu, D. He, F. Mao, X. Rao, Y. Zhao, N. A. Lanman, M. Kazemian, E. Farah, J. Liu, C. M. Ngule, Z. Zhang, Y. Zhang, Y. Kong, L. Li, C. Wang, and X. Liu. "Gstm2 Is a Key Molecular Determinant of Resistance to Sg-Aris." Oncogene (Aug 29 2022).
3. Zhang, Z., L. Cheng, J. Li, Q. Qiao, A. Karki, D. B. Allison, N. Shaker, K. Li, S. M. Utturkar, N. M. Atallah Lanman, X. Rao, P. Rychahou, D. He, S. F. Konieczny, C. Wang, Q. Shao, B. M. Evers, and X. Liu. "Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy." Cancer Res (Aug 11 2022).
4. Yang, J. M., Y. Ren, A. Kumar, X. Xiong, J. K. Das, H. Y. Peng, L. Wang, X. Ren, Y. Zhang, C. Ji, Y. Cheng, L. Zhang, R. C. Alaniz, P. de Figueiredo, D. Fang, H. Zhou, X. Liu, J. Wang, and J. Song. "Nac1 Modulates Autoimmunity by Suppressing Regulatory T Cell-Mediated Tolerance." Sci Adv 8, no. 26 (Jul 2022): eabo0183.
5. Mao, F., Y. Kong, J. Liu, X. Rao, C. Li, K. Donahue, Y. Zhang, K. Jones, Q. Zhang, W. Xu, and X. Liu. "Diptoindonesin G Antagonizes Ar Signaling and Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer." Prostate (Mar 24 2022).
6. Farah, E., Z. Zhang, S. M. Utturkar, J. Liu, T. L. Ratliff, and X. Liu. "Targeting Dnmts to Overcome Enzalutamide Resistance in Prostate Cancer." Mol Cancer Ther 21, no. 1 (Jan 2022): 193-205.
7. Das, J. K., Y. Ren, A. Kumar, H. Y. Peng, L. Wang, X. Xiong, R. C. Alaniz, P. de Figueiredo, X. Ren, X. Liu, A. G. Ryazonov, J. M. Yang, and J. Song. "Elongation Factor-2 Kinase Is a Critical Determinant of the Fate and Antitumor Immunity of Cd8(+) T Cells." Sci Adv 8, no. 5 (Feb 4 2022): eabl9783.
8. Korns, J., X. Liu, and V. Takiar. "A Review of Plks: Thinking Outside the (Polo) Box." Mol Carcinog 61, no. 2 (Feb 2022): 254-63.

2021

1. Zhang, Z., L. Cheng, Q. Zhang, Y. Kong, D. He, K. Li, M. Rea, J. Wang, R. Wang, J. Liu, Z. Li, C. Yuan, E. Liu, Y. N. Fondufe-Mittendorf, L. Li, T. Han, C. Wang, and X. Liu. "Co-Targeting Plk1 and Dnmt3a in Advanced Prostate Cancer." Adv Sci (Weinh) 8, no. 13 (Jul 2021): e2101458.
2. Jones, K., Y. Zhang, Y. Kong, E. Farah, R. Wang, C. Li, X. Wang, Z. Zhang, J. Wang, F. Mao, X. Liu, and J. Liu. "Epigenetics in Prostate Cancer Treatment." J Transl Genet Genom 5 (2021): 341-56.

2020

1. Kong, Y., Y. Zhang, F. Mao, Z. Zhang, Z. Li, R. Wang, J. Liu, and X. Liu. "Inhibition of Ezh2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer." Mol Cancer Ther 19, no. 12 (Dec 2020): 2490-501.
2. Liu, J., D. He, L. Cheng, C. Huang, Y. Zhang, X. Rao, Y. Kong, C. Li, Z. Zhang, J. Liu, K. Jones, D. Napier, E. Y. Lee, C. Wang, and X. Liu. "P300/Cbp Inhibition Enhances the Efficacy of Programmed Death-Ligand 1 Blockade Treatment in Prostate Cancer." Oncogene 39, no. 19 (May 2020): 3939-51.
3. Li, C., N. A. Lanman, Y. Kong, D. He, F. Mao, E. Farah, Y. Zhang, J. Liu, C. Wang, Q. Wei, and X. Liu. "Inhibition of the Erythropoietin-Producing Receptor Ephb4 Antagonizes Androgen Receptor Overexpression and Reduces Enzalutamide Resistance." J Biol Chem 295, no. 16 (Apr 17 2020): 5470-83.
4. Chen, X., J. Liu, L. Cheng, C. Li, Z. Zhang, Y. Bai, R. Wang, T. Han, C. Huang, Y. Kong, F. Feng, and X. Liu. "Inhibition of Noncanonical Wnt Pathway Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer." Prostate 80, no. 3 (Feb 2020): 256-66.

2019

1. Wang, R. and X. Liu. "Epigenetic Regulation of Prostate Cancer." Genes Dis 7, no. 4 (Dec 2020): 606-13.
2. Jia, Z., Y. Nie, F. Yue, Y. Kong, L. Gu, T. P. Gavin, X. Liu, and S. Kuang. "A Requirement of Polo-Like Kinase 1 in Murine Embryonic Myogenesis and Adult Muscle Regeneration." Elife 8 (Aug 8 2019).
3. Bai, Y., Z. Zhang, L. Cheng, R. Wang, X. Chen, Y. Kong, F. Feng, N. Ahmad, L. Li, and X. Liu. "Inhibition of Enhancer of Zeste Homolog 2 (Ezh2) Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer." J Biol Chem 294, no. 25 (Jun 21 2019): 9911-23.
4. Farah, E., C. Li, L. Cheng, Y. Kong, N. A. Lanman, P. Pascuzzi, G. R. Lorenz, Y. Zhang, N. Ahmad, L. Li, T. Ratliff, and X. Liu. "Notch Signaling Is Activated in and Contributes to Resistance in Enzalutamide-Resistant Prostate Cancer Cells." J Biol Chem 294, no. 21 (May 24 2019): 8543-54.
5. Ebron, J. S., E. Shankar, J. Singh, K. Sikand, C. M. Weyman, S. Gupta, D. J. Lindner, X. Liu, M. J. Campbell, and G. C. Shukla. "Mir-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways." Cancer Res 79, no. 8 (Apr 15 2019): 1844-56.

2018

1. Kong, Y., L. Cheng, F. Mao, Z. Zhang, Y. Zhang, E. Farah, J. Bosler, Y. Bai, N. Ahmad, S. Kuang, L. Li, and X. Liu. "Inhibition of Cholesterol Biosynthesis Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer (Crpc)." J Biol Chem 293, no. 37 (Sep 14 2018): 14328-41.
2. Mao, F., J. Li, Q. Luo, R. Wang, Y. Kong, C. Carlock, Z. Liu, B. D. Elzey, and X. Liu. "Plk1 Inhibition Enhances the Efficacy of Bet Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer." Mol Cancer Ther 17, no. 7 (Jul 2018): 1554-65.
3. Zhang, Z., L. Cheng, J. Li, E. Farah, N. M. Atallah, P. E. Pascuzzi, S. Gupta, and X. Liu. "Inhibition of the Wnt/Beta-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer." Cancer Res 78, no. 12 (Jun 15 2018): 3147-62.
4. Lee, H. J., J. Li, R. E. Vickman, J. Li, R. Liu, A. C. Durkes, B. D. Elzey, S. Yue, X. Liu, T. L. Ratliff, and J. X. Cheng. "Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/Beta-Catenin Pathway." Mol Cancer Res 16, no. 6 (Jun 2018): 974-85.
5. Li, Z., Y. Kong, L. Song, Q. Luo, J. Liu, C. Shao, X. Hou, and X. Liu. "Plk1-Mediated Phosphorylation of Tsc1 Enhances the Efficacy of Rapamycin." Cancer Res 78, no. 11 (Jun 1 2018): 2864-75.
6. Wilking-Busch, M. J., M. A. Ndiaye, X. Liu, and N. Ahmad. "Rna Interference-Mediated Knockdown of Sirt1 and/or Sirt2 in Melanoma: Identification of Downstream Targets by Large-Scale Proteomics Analysis." J Proteomics 170 (Jan 6 2018): 99-109.

2017

1. Li, Z., J. Liu, J. Li, Y. Kong, G. Sandusky, X. Rao, Y. Liu, J. Wan, and X. Liu. "Polo-Like Kinase 1 (Plk1) Overexpression Enhances Ionizing Radiation-Induced Cancer Formation in Mice." J Biol Chem 292, no. 42 (Oct 20 2017): 17461-72.
2. Shao, C., Z. Li, N. Ahmad, and X. Liu. "Regulation of Pten Degradation and Nedd4-1 E3 Ligase Activity by Numb." Cell Cycle 16, no. 10 (May 19 2017): 957-67.
3. Li, Z., C. Shao, Y. Kong, C. Carlock, N. Ahmad, and X. Liu. "DNA Damage Response-Independent Role for Mdc1 in Maintaining Genomic Stability." Mol Cell Biol 37, no. 9 (May 1 2017)
4. Li, J., R. Wang, Y. Kong, M. M. Broman, C. Carlock, L. Chen, Z. Li, E. Farah, T. L. Ratliff, and X. Liu. "Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer." Mol Cancer Ther 16, no. 3 (Mar 2017): 469-79.
5. Cholewa, B. D., M. A. Ndiaye, W. Huang, X. Liu, and N. Ahmad. "Small Molecule Inhibition of Polo-Like Kinase 1 by Volasertib (Bi 6727) Causes Significant Melanoma Growth Delay and Regression in Vivo." Cancer Lett 385 (Jan 28 2017): 179-87.
6. Kanwal, R., A. R. Plaga, X. Liu, G. C. Shukla, and S. Gupta. "Micrornas in Prostate Cancer: Functional Role as Biomarkers." Cancer Lett 407 (Oct 28 2017): 9-20.
   

2016

1. Yue, F., P. Bi, C. Wang, J. Li, X. Liu, and S. Kuang. "Conditional Loss of Pten in Myogenic Progenitors Leads to Postnatal Skeletal Muscle Hypertrophy but Age-Dependent Exhaustion of Satellite Cells." Cell Rep 17, no. 9 (Nov 22 2016): 2340-53.
2. Kanwal, R., M. Datt, X. Liu, and S. Gupta. "Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases." PLoS One 11, no. 9 (2016): e0162956.
3. Shan, T., Y. Xiong, P. Zhang, Z. Li, Q. Jiang, P. Bi, F. Yue, G. Yang, Y. Wang, X. Liu, and S. Kuang. "Lkb1 Controls Brown Adipose Tissue Growth and Thermogenesis by Regulating the Intracellular Localization of Crtc3." Nat Commun 7 (Jul 27 2016): 12205.
4. Li, J., D. Gu, S. S. Lee, B. Song, S. Bandyopadhyay, S. Chen, S. F. Konieczny, T. L. Ratliff, X. Liu, J. Xie, and J. X. Cheng. "Abrogating Cholesterol Esterification Suppresses Growth and Metastasis of Pancreatic Cancer." Oncogene 35, no. 50 (Dec 15 2016): 6378-88.
5. George, J., M. Nihal, C. K. Singh, W. Zhong, X. Liu, and N. Ahmad. "Pro-Proliferative Function of Mitochondrial Sirtuin Deacetylase Sirt3 in Human Melanoma." J Invest Dermatol 136, no. 4 (Apr 2016): 809-18.
6. Chen, L., J. Li, E. Farah, S. Sarkar, N. Ahmad, S. Gupta, J. Larner, and X. Liu. "Cotargeting Hsp90 and Its Client Proteins for Treatment of Prostate Cancer." Mol Cancer Ther 15, no. 9 (Sep 2016): 2107-18.
7. Chen, L., N. Ahmad, and X. Liu. "Combining P53 Stabilizers with Metformin Induces Synergistic Apoptosis through Regulation of Energy Metabolism in Castration-Resistant Prostate Cancer." Cell Cycle 15, no. 6 (2016): 840-9.
8. Li, J., R. Wang, P. G. Schweickert, A. Karki, Y. Yang, Y. Kong, N. Ahmad, S. F. Konieczny, and X. Liu. "Plk1 Inhibition Enhances the Efficacy of Gemcitabine in Human Pancreatic Cancer." Cell Cycle 15, no. 5 (2016): 711-9.
9. Gutteridge, R. E., M. A. Ndiaye, X. Liu, and N. Ahmad. "Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics." Mol Cancer Ther 15, no. 7 (Jul 2016): 1427-35.
10. Li, J. and X. Liu. "Function of B-Cell Lymphoma 6 in Trophoblast Cells." Cell Cycle 15, no. 8 (2016): 1031.

2015

1. Liu, X. "In Vitro Chromatin Templates to Study Nucleotide Excision Repair." DNA Repair (Amst) 36 (Dec 2015): 68-76.
2. Liu, X. "Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment." Transl Oncol 8, no. 3 (Jun 2015): 185-95.
3. Li, J., A. Karki, K. B. Hodges, N. Ahmad, A. Zoubeidi, K. Strebhardt, T. L. Ratliff, S. F. Konieczny, and X. Liu. "Cotargeting Polo-Like Kinase 1 and the Wnt/Beta-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer." Mol Cell Biol 35, no. 24 (Dec 2015): 4185-98.
4. Li, Z., Y. Lu, N. Ahmad, K. Strebhardt, and X. Liu. "Low-Dose Arsenic-Mediated Metabolic Shift Is Associated with Activation of Polo-Like Kinase 1 (Plk1)." Cell Cycle 14, no. 19 (2015): 3030-9.
5. Zhang, Z., L. Chen, H. Wang, N. Ahmad, and X. Liu. "Inhibition of Plk1 Represses Androgen Signaling Pathway in Castration-Resistant Prostate Cancer." Cell Cycle 14, no. 13 (2015): 2142-8.
6. Chen, L., Z. Li, N. Ahmad, and X. Liu. "Plk1 Phosphorylation of Irs2 Prevents Premature Mitotic Exit Via Akt Inactivation." Biochemistry 54, no. 15 (Apr 21 2015): 2473-80.
7. Shao, T. and X. Liu. "Identification of Rictor as a Novel Substrate of Polo-Like Kinase 1." Cell Cycle 14, no. 5 (2015): 755-60.
8. Shao, C., N. Ahmad, K. Hodges, S. Kuang, T. Ratliff, and X. Liu. "Inhibition of Polo-Like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer." J Biol Chem 290, no. 4 (Jan 23 2015): 2024-33.
9. Wang, C., W. Liu, Z. Liu, L. Chen, X. Liu, and S. Kuang. "Hypoxia Inhibits Myogenic Differentiation through P53 Protein-Dependent Induction of Bhlhe40 Protein." J Biol Chem 290, no. 50 (Dec 11 2015): 29707-16.
10. Singh, C. K., X. Liu, and N. Ahmad. "Resveratrol, in Its Natural Combination in Whole Grape, for Health Promotion and Disease Management." Ann N Y Acad Sci 1348, no. 1 (Aug 2015): 150-60.

2014

1. Anwar, M. A., W. A. Kheir, S. Eid, J. Fares, X. Liu, A. H. Eid, and A. A. Eid. "Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor Behind the Scene." J Cancer 5, no. 9 (2014): 736-44.
2. Burcham, G. N., G. M. Cresswell, P. W. Snyder, L. Chen, X. Liu, S. A. Crist, M. D. Henry, and T. L. Ratliff. "Impact of Prostate Inflammation on Lesion Development in the Poet3(+)Pten(+/-) Mouse Model of Prostate Carcinogenesis." Am J Pathol 184, no. 12 (Dec 2014): 3176-91.
3. Bi, P., T. Shan, W. Liu, F. Yue, X. Yang, X. R. Liang, J. Wang, J. Li, N. Carlesso, X. Liu, and S. Kuang. "Inhibition of Notch Signaling Promotes Browning of White Adipose Tissue and Ameliorates Obesity." Nat Med 20, no. 8 (Aug 2014): 911-8.
4. Yue, S., J. Li, S. Y. Lee, H. J. Lee, T. Shao, B. Song, L. Cheng, T. A. Masterson, X. Liu, T. L. Ratliff, and J. X. Cheng. "Cholesteryl Ester Accumulation Induced by Pten Loss and Pi3k/Akt Activation Underlies Human Prostate Cancer Aggressiveness." Cell Metab 19, no. 3 (Mar 4 2014): 393-406.
5. Zhang, Z., X. Hou, C. Shao, J. Li, J. X. Cheng, S. Kuang, N. Ahmad, T. Ratliff, and X. Liu. "Plk1 Inhibition Enhances the Efficacy of Androgen Signaling Blockade in Castration-Resistant Prostate Cancer." Cancer Res 74, no. 22 (Nov 15 2014): 6635-47.
6. Li, Z., J. Li, P. Bi, Y. Lu, G. Burcham, B. D. Elzey, T. Ratliff, S. F. Konieczny, N. Ahmad, S. Kuang, and X. Liu. "Plk1 Phosphorylation of Pten Causes a Tumor-Promoting Metabolic State." Mol Cell Biol 34, no. 19 (Oct 1 2014): 3642-61.

2013

1. Cholewa, B. D., X. Liu, and N. Ahmad. "The Role of Polo-Like Kinase 1 in Carcinogenesis: Cause or Consequence?" Cancer Res 73, no. 23 (Dec 1 2013): 6848-55.
2. Shen, M., Y. Cai, Y. Yang, X. Yan, X. Liu, and T. Zhou. "Centrosomal Protein For20 Is Essential for S-Phase Progression by Recruiting Plk1 to Centrosomes." Cell Res 23, no. 11 (Nov 2013): 1284-95.
3. Liu, W., T. Shan, X. Yang, S. Liang, P. Zhang, Y. Liu, X. Liu, and S. Kuang. "A Heterogeneous Lineage Origin Underlies the Phenotypic and Molecular Differences of White and Beige Adipocytes." J Cell Sci 126, no. Pt 16 (Aug 15 2013): 3527-32.
4. Hou, X., Z. Li, W. Huang, J. Li, C. Staiger, S. Kuang, T. Ratliff, and X. Liu. "Plk1-Dependent Microtubule Dynamics Promotes Androgen Receptor Signaling in Prostate Cancer." Prostate 73, no. 12 (Sep 2013): 1352-63.
5. Song, B., X. S. Liu, S. J. Rice, S. Kuang, B. D. Elzey, S. F. Konieczny, T. L. Ratliff, T. Hazbun, E. G. Chiorean, and X. Liu. "Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer." Mol Cancer Ther 12, no. 1 (Jan 2013): 58-68.

2012

1. Liu, W., Y. Wen, P. Bi, X. Lai, X. S. Liu, X. Liu, and S. Kuang. "Hypoxia Promotes Satellite Cell Self-Renewal and Enhances the Efficiency of Myoblast Transplantation." Development 139, no. 16 (Aug 2012): 2857-65.
2. Iliuk, A., X. S. Liu, L. Xue, X. Liu, and W. A. Tao. "Chemical Visualization of Phosphoproteomes on Membrane." Mol Cell Proteomics 11, no. 9 (Sep 2012): 629-39.
3. Liu, X. S., B. Song, J. Tang, W. Liu, S. Kuang, and X. Liu. "Plk1 Phosphorylates Sgt1 at the Kinetochores to Promote Timely Kinetochore-Microtubule Attachment." Mol Cell Biol 32, no. 19 (Oct 2012): 4053-67.
4. Luo, J. and X. Liu. "Polo-Like Kinase 1, on the Rise from Cell Cycle Regulation to Prostate Cancer Development." Protein Cell 3, no. 3 (Mar 2012): 182-97.
5. Song, B., X. S. Liu, and X. Liu. "Polo-Like Kinase 1 (Plk1): An Unexpected Player in DNA Replication." Cell Div 7 (Feb 6 2012): 3.

2011

1. Song, B., K. Davis, X. S. Liu, H. G. Lee, M. Smith, and X. Liu. "Inhibition of Polo-Like Kinase 1 Reduces Beta-Amyloid-Induced Neuronal Cell Death in Alzheimer's Disease." Aging (Albany NY) 3, no. 9 (Sep 2011): 846-51.
2. Song, B., X. S. Liu, K. Davis, and X. Liu. "Plk1 Phosphorylation of Orc2 Promotes DNA Replication under Conditions of Stress." Mol Cell Biol 31, no. 23 (Dec 2011): 4844-56.
3. Liu, X. S., B. Song, B. D. Elzey, T. L. Ratliff, S. F. Konieczny, L. Cheng, N. Ahmad, and X. Liu. "Polo-Like Kinase 1 Facilitates Loss of Pten Tumor Suppressor-Induced Prostate Cancer Formation." J Biol Chem 286, no. 41 (Oct 14 2011): 35795-800.

2010

1. Li, H., X. S. Liu, X. Yang, Y. Wang, Y. Wang, J. R. Turner, and X. Liu. "Phosphorylation of Clip-170 by Plk1 and Ck2 Promotes Timely Formation of Kinetochore-Microtubule Attachments." EMBO J 29, no. 17 (Sep 1 2010): 2953-65.
2. Li, H., X. S. Liu, X. Yang, B. Song, Y. Wang, and X. Liu. "Polo-Like Kinase 1 Phosphorylation of P150glued Facilitates Nuclear Envelope Breakdown During Prophase." Proc Natl Acad Sci U S A 107, no. 33 (Aug 17 2010): 14633-8.
3. Liu, X. S., H. Li, B. Song, and X. Liu. "Polo-Like Kinase 1 Phosphorylation of G2 and S-Phase-Expressed 1 Protein Is Essential for P53 Inactivation During G2 Checkpoint Recovery." EMBO Rep 11, no. 8 (Aug 2010): 626-32.
4. Yang, X., H. Li, A. Deng, and X. Liu. "Plk1 Phosphorylation of Topors Is Involved in Its Degradation." Mol Biol Rep 37, no. 6 (Jul 2010): 3023-8.
5. Studach, L., W. H. Wang, G. Weber, J. Tang, R. L. Hullinger, R. Malbrue, X. Liu, and O. Andrisani. "Polo-Like Kinase 1 Activated by the Hepatitis B Virus X Protein Attenuates Both the DNA Damage Checkpoint and DNA Repair Resulting in Partial Polyploidy." J Biol Chem 285, no. 39 (Sep 24 2010): 30282-93.
6. Liu, X. S., B. Song, and X. Liu. "The Substrates of Plk1, Beyond the Functions in Mitosis." Protein Cell 1, no. 11 (Nov 2010): 999-1010.
7. Liu, X. "Sbe13 Joins the Family of Polo-Like Kinase 1 (Plk1) Inhibitors." Cell Cycle 9, no. 3 (Feb 1 2010): 445-6.

2009

1. Liu, X. "Plk1, a Negative Regulator of P21?" Cell Cycle 8, no. 3 (Feb 1 2009): 336-7.
2. Yang, X., H. Li, X. S. Liu, A. Deng, and X. Liu. "Cdc2-Mediated Phosphorylation of Clip-170 Is Essential for Its Inhibition of Centrosome Reduplication." J Biol Chem 284, no. 42 (Oct 16 2009): 28775-82.
3. Yang, X., H. Li, Z. Zhou, W. H. Wang, A. Deng, O. Andrisani, and X. Liu. "Plk1-Mediated Phosphorylation of Topors Regulates P53 Stability." J Biol Chem 284, no. 28 (Jul 10 2009): 18588-92.

2008

1. Wu, Z. Q. and X. Liu. "Role for Plk1 Phosphorylation of Hbo1 in Regulation of Replication Licensing." Proc Natl Acad Sci U S A 105, no. 6 (Feb 12 2008): 1919-24.
2. Li, H., Y. Wang, and X. Liu. "Plk1-Dependent Phosphorylation Regulates Functions of DNA Topoisomerase Iialpha in Cell Cycle Progression." J Biol Chem 283, no. 10 (Mar 7 2008): 6209-21.
3. Wu, Z. Q., X. Yang, G. Weber, and X. Liu. "Plk1 Phosphorylation of Trf1 Is Essential for Its Binding to Telomeres." J Biol Chem 283, no. 37 (Sep 12 2008): 25503-13.
4. Tang, J., X. Yang, and X. Liu. "Phosphorylation of Plk1 at Ser326 Regulates Its Functions During Mitotic Progression." Oncogene 27, no. 52 (Nov 6 2008): 6635-45.

2007

1. Liu, X. and R. L. Erikson. "The Nuclear Localization Signal of Mitotic Kinesin-Like Protein Mklp-1: Effect on Mklp-1 Function During Cytokinesis." Biochem Biophys Res Commun 353, no. 4 (Feb 23 2007): 960-4.